Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124928475 | 12492847 | 5 | F | 201606 | 20160812 | 20160623 | 20160817 | PER | US-PFIZER INC-2016313122 | PFIZER | 53.00 | YR | M | Y | 141.50000 | KG | 20160817 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124928475 | 12492847 | 1 | PS | VIAGRA | SILDENAFIL CITRATE | 1 | Oral | 100 MG, AS NEEDED (BEFORE BED) | 20895 | 100 | MG | FILM-COATED TABLET | |||||||
| 124928475 | 12492847 | 2 | SS | VIAGRA | SILDENAFIL CITRATE | 1 | UNK | 20895 | FILM-COATED TABLET | ||||||||||
| 124928475 | 12492847 | 3 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 20 MG, 1X/DAY | 0 | 20 | MG | CAPSULE | QD | ||||||
| 124928475 | 12492847 | 4 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Oral | 50 MG, 1X/DAY (EVERY MORNING) | 0 | 50 | MG | TABLET | QD | ||||||
| 124928475 | 12492847 | 5 | C | FLUOXETINE | FLUOXETINE HYDROCHLORIDE | 1 | Oral | 20 MG, 1X/DAY (IN THE MORNING) | 0 | 20 | MG | CAPSULE | QD | ||||||
| 124928475 | 12492847 | 6 | C | COLCHICINE. | COLCHICINE | 1 | Oral | 6 MG, UNK | 0 | 6 | MG | ||||||||
| 124928475 | 12492847 | 7 | C | DIPHENHYDRAMINE. | DIPHENHYDRAMINE | 1 | Oral | 25 MG, 1X/DAY (EVERY DAYTIME) | 0 | 25 | MG | CAPSULE | QD | ||||||
| 124928475 | 12492847 | 8 | C | DIAZEPAM. | DIAZEPAM | 1 | Oral | 10 MG, 1X/DAY (EVERY NIGHT) | 0 | 10 | MG | TABLET | QD | ||||||
| 124928475 | 12492847 | 9 | C | BUPROPION HCL | BUPROPION HYDROCHLORIDE | 1 | Oral | 150 MG, 2X/DAY | 0 | 150 | MG | TABLET | BID | ||||||
| 124928475 | 12492847 | 10 | C | TERAZOSIN | TERAZOSINTERAZOSIN HYDROCHLORIDE | 1 | Oral | 2 MG, 1X/DAY (EVERY MORNING) | 0 | 2 | MG | CAPSULE | QD | ||||||
| 124928475 | 12492847 | 11 | C | IBUPROFEN. | IBUPROFEN | 1 | Oral | 800 MG, 1X/DAY (EVERY MORNING) | 0 | 800 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124928475 | 12492847 | 3 | Flatulence |
| 124928475 | 12492847 | 4 | Blood pressure abnormal |
| 124928475 | 12492847 | 5 | Hallucination, auditory |
| 124928475 | 12492847 | 6 | Arthritis |
| 124928475 | 12492847 | 7 | Disability |
| 124928475 | 12492847 | 10 | Neuropathy peripheral |
| 124928475 | 12492847 | 11 | Musculoskeletal disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124928475 | 12492847 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124928475 | 12492847 | Drug ineffective | |
| 124928475 | 12492847 | Product quality issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |